Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell Improve Cardiac Function on ST-elevation Myocardial Infarction (STEMI) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update exploring umbilical cord mesenchymal stem cells to improve cardiac function after ST-elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Indonesia University | Conditions: ST Elevation Myocardial Infarction | Phase 3 | Status: UNKNOWN